Search

Author/Creator Späth, Hans-Martin

1. COST-EFFECTIVENESS OF TREATMENTS FOR MILD-TO-MODERATE OBSTRUCTIVE SLEEP APNEA IN FRANCE. (9th March 2016)

Authors:
Poullié, Anne-Isabelle; Cognet, Magali; Gauthier, Aline; Clementz, Marine; Druais, Sylvain; Späth, Hans-Martin; Perrier, Lionel; Scemama, Oliver; Pichon, Catherine Rumeau; Harousseau, Jean-Luc
Journal:
International journal of technology assessment in health care
Issue:
Volume 32:Number 1/2(2016)
Page Start:
37
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Ocrelizumab not recommended in France for patients with primary progressive multiple sclerosis while recommended in England: a review comparing the assessment by HAS and NICE. (3rd June 2021)

Authors:
Armoiry, Xavier; Späth, Hans-Martin; Henaine, Anna-Maria; Dussart, Claude; Counsell, Carl; Connock, Martin
Journal:
Expert opinion on biological therapy
Issue:
Volume 21:Number 6(2021)
Page Start:
741
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗